Results 121 to 130 of about 148,492 (237)

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. [PDF]

, 1993
Herbert Tilg, Edouard Vannier, Gloria Vachino, Charles A. Dinarello, J W Mier   +4 more
openalex   +1 more source

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer.

, 1993
Geethani Bandara, G M Mueller, Joanna Galea‐Lauri, M H Tindal, H. I. Georgescu, Maureen K. Suchanek, G L Hung, Joseph C. Glorioso, Paul D. Robbins, C H Evans   +9 more
openalex   +1 more source

Interleukin 1 Induces HIV-1 Expression in Chronically Infected U1 Cells: Blockade by Interleukin 1 Receptor Antagonist and Tumor Necrosis Factor Binding Protein Type 1 [PDF]

, 1995
Eric V. Granowitz, Bradford M. Saget, Monica Z. Wang, C A Dinarello, Paul R. Skolnik, Anthony S. Fauci   +5 more
openalex   +1 more source

Inhaled Interleukin-10 before and after induction of experimental endotoxemia in the rat : effects on the inflammatory response [PDF]

, 2007
To determine the effects of inhaled IL-10 at different doses and different time points on the pulmonary and systemic inflammatory response during endotoxemia, 48 ventilated, anaesthetized rats (mean body weight ± standard deviation, 500 ± 33g) were ...
Nguyen, Ngoc-Thach
core  

Higher levels of IL-1ra, IL-6, IL-8, MCP-1, MIP-3α, MIP-3β, and fractalkine are associated with 90-day mortality in 132 non-immunomodulated hospitalized patients with COVID-19.

PLoS ONE
IntroductionImmune dysregulation with an excessive release of cytokines has been identified as a key driver in the development of severe COVID-19. The aim of this study was to evaluate the initial cytokine profile associated with 90-day mortality and ...
Liv Rabøl Andersen, Bettina Hindsberger, Simone Bastrup Israelsen, Lise Pedersen, Pal Bela Szecsi, Thomas Benfield   +5 more
doaj   +1 more source

Effect of dexamethasone, interleukin-1 receptor antagonist protein, and toll-like receptor antagonist 242 (resatorvid) on gene expression in equine chondrocytes in a chronic inflammation model in vitro [PDF]

, 2018
Lise Charlotte Berg, Marie Louise Honoré, Louise Bundgaard   +2 more
openalex   +1 more source

Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors

Cell Communication and Signaling
Background Interleukin (IL)-38 is an IL-1 family cytokine that was proposed to exert anti-inflammatory effects. However, its mechanisms of action are not well understood and the identity of the IL-38 receptor(s) remains debated.
Alejandro Diaz-Barreiro, Dominique Talabot-Ayer, Arnaud Huard, Gea Cereghetti, Jenna Tonacini, Mike Maillasson, Antonio Francés-Monerris, Erwan Mortier, Gaby Palmer   +8 more
doaj   +1 more source

Changes in haematological indices following local application of interleukin-1 receptor antagonist protein after tenotomy in rabbits [PDF]

, 2017
Marko Pećin, Marija Lipar, Ozren Smolec, Boris Pirkić, Andrija Musulin, Josip Kos   +5 more
openalex   +1 more source

Brain immune interactions and air pollution: macrophage inhibitory factor (MIF), prion cellular protein (PrPC), Interleukin-6 (IL-6), interleukin 1 receptor antagonist (IL-1Ra), and interleukin-2 (IL-2) in cerebrospinal fluid and MIF in serum differentiate urban children exposed to severe vs. low air pollution [PDF]

, 2013
Lilian Calderón‐Garcidueñas, Janet V. Cross, Maricela Franco-Lira, Mariana Aragón-Flores, Michael Kavanaugh, Ricardo Torres‐Jardón, Chih‐Kai Chao, Charles Thompson, Jing Chang, Hongtu Zhu, Amedeo D’Angiulli   +10 more
openalex   +1 more source

Influence of interleukin-1 receptor antagonist on dynamics of the glutathione system, energy metabolism and oxydative protein modification in experimental hyperglycemia

, 2014
A. S. Suprun, И. Ф. Беленичев
openalex   +2 more sources